Skip to content
healthcare.dev
Get a free key

ALYMSYS

NDC 85006-1754, bevacizumab-maly, injection, solution, from Valorum Biologics, LLC.

Product NDC
85006-1754
Status
Listed
Labeler
Valorum Biologics, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761231
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85006-1754 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BEVACIZUMAB-MALY100 mg/4mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]; Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
85006-1754-1850061754011 VIAL in 1 CARTON (85006-1754-1) / 4 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/42b4f96e-1f70-2126-e063-6294a90a93e3

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=85006-1754

Use it

Look up 85006-1754 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85006-1754 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85006-1754. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.